SMTL ID : 6qgk.1

Structure of human Bcl-2 in complex with THIQ-phenyl pyrazole compound

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x J1Q: 1-[2-[[(3~{S})-3-(aminomethyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]carbonyl]phenyl]-~{N},~{N}-dibutyl-5-methyl-pyrazole-3-carboxamide(Non-covalent)

J1Q.1: 12 residues within 4Å: Chain A: F.56, Y.60, D.63, F.64, M.67, V.85, E.88, L.89, R.98, A.101, F.105 Ligands: ACT.2 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:F.56, A:Y.60, A:D.63, A:F.64, A:E.88, A:L.89, A:F.105 Water bridges: A:D.63 pi-Stacking: A:F.64

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.2: 2 residues within 4Å: Chain A: R.98 Ligands: J1Q.1 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.98

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Murray, J.B. et al., Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1. Acs Omega (2019)

Release Date

2019-06-12

Peptides

Apoptosis regulator Bcl-2,Bcl-2-like protein 1,Apoptosis regulator Bcl-2,Bcl-2-like protein 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Apoptosis regulator Bcl-2,Bcl-2-like protein 1,Apoptosis regulator Bcl-2,Bcl-2-like protein 1